Gene expression profiles in the olfactory bulb from a rat model of Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 18, Issue 3, 2009, Pages 581-593

  Zhu, Ying Ying ^a   Ni, Dao Feng ^a   Xu, Cai Min ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Alzheimer's disease; Gene expression profile; Microarray; Olfactory bulb; Rat

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CALCINEURIN; PROTEIN KINASE C;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION PROFILING; MALE; MAZE TEST; MEMORY DISORDER; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; OLFACTORY RECEPTOR; OLFACTORY SYSTEM; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 75149132053     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1201     Document Type: Article

References (46)

1. Kelley BJ, Petersen RC (2007) Alzheimer's disease and mild cognitive impairment. Neurol Clin 25, 577-609, v.
2. Jellinger KA (2008) Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 5, 118-121.
3. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739, 198-210.
4. Kovacs T, Cairns NJ, Lantos PL (2001) Olfactory centres in Alzheimer's disease: olfactory bulb is involved in early Braak's stages. Neuroreport 12, 285-288.
5. Burry R (1983) Antimitotic drugs that enhance neuronal survival in olfactory bulb cell cultures. Brain Res 261, 261-275.
6. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, Harrison T, Lellis C, Nadin A, Neduvelil JG, Register RB, Sardana MK, Shearman MS, Smith AL, Shi XP, Yin KC, Shafer JA, Gardell SJ (2000) Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689-694.
7. Monji A, Utsumi H, Ueda T, Imoto T, Yoshida I, Hashioka S, Tashiro K, Tashiro N (2002) Amyloid-beta-protein (A beta) (25-35)-associated free radical generation is strongly influenced by the aggregational state of the peptides. Life Sci 70, 833-841.
8. Pozhitkov AE, Tautz D, Noble PA (2007) Oligonucleotide microarrays: widely applied-poorly understood. Brief Funct Genomic Proteomic 6, 141-148.
9. Hardy J (2006) Has the amyloid cascade hypothesis for Alzheimer's disease been proved? Curr Alzheimer Res 3, 71-73.
10. Shukitt-Hale B, McEwen JJ, Szprengiel A, Joseph JA (2004) Effect of age on the radial arm water maze-a test of spatial learning and memory. Neurobiol Aging 25, 223-229.
11. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L (1984) Smell identification ability: changes with age. Science 226, 1441-1443.
12. Burns A (2000) Might olfactory dysfunction be a marker of early Alzheimer's disease? Lancet 355, 84-85.
13. Henkin RI (2000) Olfactory dysfunction in Alzheimer's disease. Lancet 355, 1014-1015.
14. Koss E,Weiffenbach JM, Haxby JV, Friedland RP (1988) Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 38, 1228-1232.
15. Kovacs T, Cairns NJ, Lantos PL (1999) beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 25, 481-491.
16. Polani PE (2000) Olfactory dysfunction in Alzheimer's disease. Lancet 355, 1015.
17. Serby M, Corwin J, Conrad P, Rotrosen J (1985) Olfactory dysfunction in Alzheimer's disease and Parkinson's disease. Am J Psychiatry 142, 781-782.
18. Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62, 436-446.
19. Kranick SM, Duda JE (2008) Olfactory dysfunction in Parkinson's disease. Neurosignals 16, 35-40.
20. Mansoor MR, Prichard DR, Hobson JP, Meara RJ (1999) Clinical assessment of olfactory dysfunction in Parkinson's disease. Mov Disord 14, 385-386.
21. Murofushi T, Mizuno M, Osanai R, Hayashida T (1991) Olfactory dysfunction in Parkinson's disease. ORL J Otorhinolaryngol Relat Spec 53, 143-146.
22. Potagas C, Dellatolas G, Ziegler M, Leveteau J, Bathien N, Mac Leod P, Rondot P (1998) Clinical assessment of olfactory dysfunction in Parkinson's disease. Mov Disord 13, 394-399.
23. Quagliato LB, Viana MA, Quagliato EM, Simis S (2007) [Olfactory dysfunction in Parkinson's disease]. Arq Neuropsiquiatr 65, 647-652.
24. Wszolek ZK, Markopoulou K (1998) Olfactory dysfunction in Parkinson's disease. Clin Neurosci 5, 94-101.
25. Hawkes CH, Shephard BC, Geddes JF, Body GD, Martin JE (1998) Olfactory disorder in motor neuron disease. Exp Neurol 150, 248-253.
26. Chung S, Lee J, Joe EH, Uhm DY (2001) Beta-amyloid peptide induces the expression of voltage dependent outward rectifying K+ channels in rat microglia. Neurosci Lett 300, 67-70.
27. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890.
28. Harkany T, Abraham I, Konya C, Nyakas C, Zarandi M, Penke B, Luiten PG (2000) Mechanisms of beta-amyloid neurotoxi city: perspectives of pharmacotherapy. Rev Neurosci 11, 329-382.
29. Le WD, Xie WJ, Kong R, Appel SH (1997) Beta-amyloidinduced neurotoxicity of a hybrid septal cell line associated with increased tau phosphorylation and expression of betaamyloid precursor protein. J Neurochem 69, 978-985.
30. Fraser SP, Suh YH, Djamgoz MB (1997) Ionic effects of the Alzheimer's disease beta-amyloid precursor protein and its metabolic fragments. Trends Neurosci 20, 67-72.
31. Pasinetti GM (1996) Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol Aging 17, 707-716.
32. Luskin MB (1993) Restricted proliferation and migration of postnatally generated neurons derived from the forebrain subventricular zone. Neuron 11, 173-189.
33. Blumenthal DK TK, Hansen RS, Krebs EG (1986) Dephosphorylation of cAMP-dependent protein kinase regulatory subunit (type II) by calmodulin-dependent protein phosphatase. Determinants of substrate specificity. J Biol Chem 261, 8140-8145.
34. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2006) Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target. J Biomed Biotechnol 2006, 31825.
35. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1994) Alzheimer's disease abnormally phosphorylated tau is dephosphorylated by protein phosphatase-2B (calcineurin). J Neurochem 62, 803-806.
36. Yamamoto H, Hasegawa M, Ono T, Tashima K, Ihara Y, Miyamoto E (1995) Dephosphorylation of fetal-tau and paired helical filaments-tau by protein phosphatases 1 and 2A and calcineurin. J Biochem 118, 1224-1231.
37. Garver TD, Kincaid RL, Conn RA, Billingsley ML (1999) Reduction of calcineurin activity in brain by antisense oligonucleotides leads to persistent phosphorylation of tau protein at Thr181 and Thr231. Mol Pharmacol 55, 632-641.
38. Yu DY, Luo J, Bu F, Song GJ, Zhang LQ, Wei Q (2006) Inhibition of calcineurin by infusion of CsA causes hyperphosphorylation of tau and is accompanied by abnormal behavior in mice. Biol Chem 387, 977-983.
39. Liu F, Grundke-Iqbal I, Iqbal K, OdaY, Tomizawa K,GongCX (2005) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 280, 37755-37762.
40. Klee CB, Ren H,WangX(1998) Regulation of the calmodulinstimulated protein phosphatase, calcineurin. J Biol Chem 273, 13367-13370.
41. Guan GM, Liu TY, Dong Z (2002) Study of relationship between protein kinase C and apoptosis gene protein in olfactory bulb of rats. Chin J Otorhinolaryngol Head Neck Surg 9, 113-115.
42. Margolis FL (1982) Olfactory marker protein (OMP). Scand J Immunol Suppl 9, 181-199.
43. Takami S, Getchell ML, Chen Y, Monti-Bloch L, Berliner DL, Stensaas LJ, Getchell TV (1993) Vomeronasal epithelial cells of the adult human express neuron-specific molecules. Neuroreport 4, 375-378.
44. Suzuki Y, Takeda M (1991) Basal cells in the mouse olfactory epithelium after axotomy: immunohistochemical and electron-microscopic studies. Cell Tissue Res 266, 239-245.
45. Heilmann S, Hummel T, Margolis FL, Kasper M, Witt M (2000) Immunohistochemical distribution of galectin-1, galectin-3, and olfactory marker protein in human olfactory epithelium. Histochem Cell Biol 113, 241-245.
46. Davies DC, Brooks JW, Lewis DA (1993) Axonal loss from the olfactory tracts in Alzheimer's disease. Neurobiol Aging 14, 353-357.